This flu season has been rough for patients, doctors, pharmacies, employers, and almost everyone else.
Getting a yearly flu shot is the best way to prevent yourself from getting the seasonal flu according to the Centers for Disease Control and Prevention (CDC). However, as with most things in life, getting a flu shot does not 100% guarantee that you will not get the flu.
But, there is good news. You may find relief in knowing that Shionogi Inc., a pharmaceutical company in Japan, is currently testing a new treatment that could kill the flu virus with just one dose of medication – destroying the flu in just a single day.
This potential new medication, baloxavir marboxil (Xofluza), is currently finishing up Phase III clinical trials in healthy patients but is still being conducted in pediatric and high-risk patients.
When could we see this drug in the United States?
Baloxavir marboxil has been approved and is expected to be available in Japan as early as May 2018 as it’s currently being fast-tracked. Also, if everything goes as expected we could see baloxavir marboxil available in the United States by 2019.
In the meantime, you can read more about other flu medications here.
How will baloxavir marboxil dosing differ from current oral treatments?
Baloxavir marboxil is dosed as 1 pill once whereas current treatments are to be taken as follows:
- Tamiflu (oseltamivir) is 1 pill twice daily for 5 days
- Relenza (zanamivir) is 2 inhalations twice daily for 5 days
We've sent a link to download the GoodRx mobile app to your phone.
We were unable to send a link to your phone.